Servier prepares to rebuff criticism on Mediator slimming drug scandal
This article was originally published in Scrip
Executive Summary
The private firm Servier will be replying to the recent French government report that portrayed it in a negative light relating to its now withdrawn slimming drug Mediator (benfluorex) which has been associated with between 500 to 2,000 deaths as a result of heart valve damage.